Latest Breaking News On - Reshape lifesciences - Page 1 : comparemela.com

ReShape Lifesciences Inc. (NASDAQ:RSLS) Sees Significant Increase in Short Interest

ReShape Lifesciences Inc. (NASDAQ:RSLS – Get Free Report) was the recipient of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 2,170,000 shares, a growth of 598.6% from the May 15th total of 310,600 shares. Currently, 10.4% of the shares of the stock are […]

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Why ReShape Lifesciences Stock Is Moving Higher Wednesday - Reshape Lifesciences (NASDAQ:RSLS)

ReShape Lifesciences reported that it gained approval from the United States Patent and Trademark Office for its application entitled, "Intragastric Device (For Treating Obesity)." In the patent filings, the company described the product as a swallowable implant that expands via a balloon in the stomach to induce a feeling of fullness, helping to restrict food intake.

Comparing ReShape Lifesciences (NASDAQ:RSLS) and ICU Medical (NASDAQ:ICUI)

ReShape Lifesciences (NASDAQ:RSLS – Get Free Report) and ICU Medical (NASDAQ:ICUI – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, analyst recommendations, earnings, dividends, risk, institutional ownership and valuation. Risk and Volatility ReShape Lifesciences has a beta […]

ReShape Lifesciences Inc. (NASDAQ:RSLS) Q1 2024 Earnings Call Transcript

Michael Miller: Good afternoon, and thank you for joining the first quarter 2024 ReShape Lifesciences earnings call.